Salamanca

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Mantle cell lymphoma1 trial
• Multiple myeloma1 trial

Phase

• Phase 11 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Celgene2 trials

Closed trials

• Terminated

  Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

  NCT04855136· Phase 1· Celgene· Source

• Completed

  A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma

  NCT03647124· Celgene· Source